Book contents
- International Compendium of Movement Disorders
- International Compendium of Movement Disorders
- Copyright page
- Contents
- Contributors
- International Compendium of Movement Disorders
- Hypo- and Hyperkinetic, Dyscoordinative and Otherwise Inappropriate Motor and Behavioral Movement Disorders
- Section 1: Basic Introduction
- Section 2: Hypokinetic Movement Disorders
- Chapter 12 Autonomic Dysfunction in Parkinson’s Disease
- Chapter 13 Neuropsychiatric Manifestations in Parkinson Disease
- Chapter 14 Sleep–Wake Disorders in Parkinson’s Disease
- Chapter 15 Neuronal Activity in the Basal Ganglia and Thalamus in Patients with Parkinson’s Disease
- Chapter 16 Pathology in Parkinson’s Disease
- Chapter 17 Diagnosis of Parkinson’s Disease
- Chapter 18 Prodromal Manifestations of Parkinson’s Disease
- Chapter 19 Biomarkers in Parkinson’s Disease
- Chapter 20 Physical Rehabilitation of Patients with Parkinson’s Disease
- Chapter 21 Regenerative Strategies for Parkinson’s Disease
- Chapter 22 Conventional Pharmacotherapy in Parkinson’s Disease
- Chapter 23 Continuous Dopaminergic Stimulation in Parkinson’s Disease
- Chapter 24 Pipeline of Pharmacotherapy in Parkinson’s Disease
- Chapter 25 Non-Invasive Brain Stimulation for the Treatment of Parkinson’s Disease
- Chapter 26 Deep Brain Stimulation in Parkinson’s Disease
- Chapter 27 Focused Ultrasound in Parkinson’s Disease
- Chapter 28 Dementia with Lewy Bodies
- Chapter 29 Genetic Parkinsonisms
- Chapter 30 Multiple System Atrophy
- Chapter 31 Progressive Supranuclear Palsy
- Chapter 32 Corticobasal Degeneration and Corticobasal Syndrome
- Chapter 33 Other Tau-Related Parkinsonisms
- Chapter 34 Vascular Parkinsonism
- Chapter 35 Illicit Drug–Induced Parkinsonism
- Section 3: Hyperkinetic Movement Disorders
- Section 4: Dyscoordinative and Otherwise Inappropriate Motor Behaviors
- Section 5: Objectifying Movement Disorders
- Movement Disorders in Vivo: Video Fragments
- Acronyms and Abbreviations
- Index
- References
Chapter 34 - Vascular Parkinsonism
from Section 2: - Hypokinetic Movement Disorders
Published online by Cambridge University Press: 07 January 2025
- International Compendium of Movement Disorders
- International Compendium of Movement Disorders
- Copyright page
- Contents
- Contributors
- International Compendium of Movement Disorders
- Hypo- and Hyperkinetic, Dyscoordinative and Otherwise Inappropriate Motor and Behavioral Movement Disorders
- Section 1: Basic Introduction
- Section 2: Hypokinetic Movement Disorders
- Chapter 12 Autonomic Dysfunction in Parkinson’s Disease
- Chapter 13 Neuropsychiatric Manifestations in Parkinson Disease
- Chapter 14 Sleep–Wake Disorders in Parkinson’s Disease
- Chapter 15 Neuronal Activity in the Basal Ganglia and Thalamus in Patients with Parkinson’s Disease
- Chapter 16 Pathology in Parkinson’s Disease
- Chapter 17 Diagnosis of Parkinson’s Disease
- Chapter 18 Prodromal Manifestations of Parkinson’s Disease
- Chapter 19 Biomarkers in Parkinson’s Disease
- Chapter 20 Physical Rehabilitation of Patients with Parkinson’s Disease
- Chapter 21 Regenerative Strategies for Parkinson’s Disease
- Chapter 22 Conventional Pharmacotherapy in Parkinson’s Disease
- Chapter 23 Continuous Dopaminergic Stimulation in Parkinson’s Disease
- Chapter 24 Pipeline of Pharmacotherapy in Parkinson’s Disease
- Chapter 25 Non-Invasive Brain Stimulation for the Treatment of Parkinson’s Disease
- Chapter 26 Deep Brain Stimulation in Parkinson’s Disease
- Chapter 27 Focused Ultrasound in Parkinson’s Disease
- Chapter 28 Dementia with Lewy Bodies
- Chapter 29 Genetic Parkinsonisms
- Chapter 30 Multiple System Atrophy
- Chapter 31 Progressive Supranuclear Palsy
- Chapter 32 Corticobasal Degeneration and Corticobasal Syndrome
- Chapter 33 Other Tau-Related Parkinsonisms
- Chapter 34 Vascular Parkinsonism
- Chapter 35 Illicit Drug–Induced Parkinsonism
- Section 3: Hyperkinetic Movement Disorders
- Section 4: Dyscoordinative and Otherwise Inappropriate Motor Behaviors
- Section 5: Objectifying Movement Disorders
- Movement Disorders in Vivo: Video Fragments
- Acronyms and Abbreviations
- Index
- References
Summary
Vascular parkinsonism (VP) is a clinical entity within the broader context of parkinsonian syndromes and usually manifests with an array of clinical features including a mainly lower body motor parkinsonism with a gait disorder, corticospinal and pseudobulbar signs and symptoms, urinary incontinence, dementia, and pyramidal and cerebellar signs. As the name suggests, etiologically VP may be defined as a secondary parkinsonian syndrome occurring in relation to ischemic cerebrovascular disease. Treatment for VP remains challenging as available data on the efficacy of current treatment options are contentious. VP is generally considered to be poorly responsive to levodopa, the most effective of the current treatment modalities for parkinsonism; however, there is evidence that some patients benefit from therapy with levodopa, especially in case of underlying ischemic or hemorrhagic lesions in the substantia nigra, globus pallidus pars externa, thalamic ventral lateral nuclei, or nigrostriatal pathway, leading to presynaptic dopamine transporter deficiency as measured by single photon emission computed tomography.
Keywords
- Type
- Chapter
- Information
- International Compendium of Movement Disorders , pp. 414 - 422Publisher: Cambridge University PressPrint publication year: 2025